MAT2A-IN-21
MAT2A-IN-21 (compound 28) is a potent methionine adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 49 nM. MAT2A-IN-21 selectivity inhibits MTAP-deficient cancer cells[1].
Product Specifications
CAS Number
[3062073-94-0]
UNSPSC
12352005
Target
Methionine Adenosyltransferase (MAT)
Related Pathways
Epigenetics; Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
O=C1C(C2=CC3=C(C=C2)N=CN3C)=NC4=CC=C(C=C4N1C5=CC=C(C=C5)OC(F)F)C6CC6
Molecular Formula
C26H20F2N4O2
Molecular Weight
458.46
References & Citations
[1]Li C, et al. Discovery of 2 (1H) -Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers. J Med Chem. 2025 Jan 6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
150150 100 µg
XRCC5 (X-ray Repair Cross-complementing Protein 5, 86kD Subunit of Ku Antigen, ATP-dependent DNA Helicase 2 Subunit 2, ATP-dependent DNA Helicase II 80kD Subunit, CTC Box-binding Factor 85kD Subunit, CTC85, CTCBF, DNA Repair Protein XRCC5, G22P2, Ku80, Ku86, Lupus Ku Autoantigen Protein p86, Nuclear Factor IV, Thyroid-lupus Autoantigen, TLAA) discontinued
Ask
View Details 